Through functional validation and correlative analyses, we reveal a previously unrecognised function of NUCB2 in driving GBM aggressiveness through parallel regulation of intrinsic tumour growth and extrinsic immune evasion mechanisms. The gene discussed is NUCB2; the disease is glioblastoma.